标题:Puromycin-sensitive aminopeptidase (PSA/NPEPPS) impedes development of neuropathology in hPSA/TAU(P301L) double-transgenic mice
作者:Kudo, Lili C.; Parfenova, Liubov; Ren, Guijie; Vi, Nancy; Hui, Maria; Ma, Zhongcai; Lau, Kimbley; Gray, Michelle; Bardag-Gorce, Fawzia 更多
作者机构:[Kudo, Lili C.; Vi, Nancy; Karsten, Stanislav L.] NeuroInDx Inc, Signal Hill, CA 90755 USA.; [Parfenova, Liubov; Ren, Guijie; Ma, Zhongcai; Lau, Kim 更多
通讯作者:Karsten, SL
通讯作者地址:[Karsten, SL]1124 W Carson St, Torrance, CA 90509 USA.
来源:HUMAN MOLECULAR GENETICS
出版年:2011
卷:20
期:9
页码:1820-1833
DOI:10.1093/hmg/ddr065
摘要:Accumulation of neurotoxic hyperphosphorylated TAU protein is a major pathological hallmark of Alzheimer disease and other neurodegenerative dementias collectively called tauopathies. Puromycin-sensitive aminopeptidase (PSA/NPEPPS) is a novel modifier of TAU-induced neurodegeneration with neuroprotective effects via direct proteolysis of TAU protein. Here, to examine the effects of PSA/NPEPPS overexpression in vivo in the mammalian system, we generated and crossed BAC-PSA/NPEPPS transgenic mice with the TAU(P301L) mouse model of neurodegeneration. PSA/NPEPPS activity in the brain and peripheral tissues of human PSA/NPEPPS (hPSA) mice was elevated by similar to 2-3-fold with no noticeable deleterious physiological effects. Double-transgenic animals for hPSA and TAU(P301L) transgenes demonstrated a distinct trend for delayed paralysis and showed significantly improved motor neuron counts, no gliosis and markedly reduced levels of total and hyperphosphorylated TAU in the spinal cord, brain stem, cortex, hippocampus and cerebellum of adult and aged animals when compared with TAU(P301L) mice. Furthermore, endogenous TAU protein abundance in human neuroblastoma SH-SY5Y cells was significantly reduced or augmented by overexpression or knockdown of PSA/NPEPPS, respectively. This study demonstrated that without showing neurotoxic effects, elevation of PSA/NPEPPS activity in vivo effectively blocks accumulation of soluble hyperphosphorylated TAU protein and slows down the disease progression in the mammalian system. Our data suggest that increasing PSA/NPEPPS activity may be a feasible therapeutic approach to eliminate accumulation of unwanted toxic substrates such as TAU.
收录类别:SCOPUS;SCIE
WOS核心被引频次:18
Scopus被引频次:19
资源类型:期刊论文
原文链接:https://www.scopus.com/inward/record.uri?eid=2-s2.0-79954492611&doi=10.1093%2fhmg%2fddr065&partnerID=40&md5=dd01e51c88c16b25ff168aad22f30948
TOP